文献速递外周动脉疾病

INVOS近红外光谱作为外周动脉疾病腔内治疗预后工具的初步研究

In-Vivo Optical Spectroscopy (INVOS) as a Prognostic Tool for Peripheral Artery Disease During Endovascular Intervention: A Pilot Study.
PubMed 文献 · J Endovasc Ther · 2025-10-02

前瞻性纳入30例外周动脉疾病(PAD)患者,在腔内治疗围术期用INVOS测量足部组织氧合,计算INVOS/收缩压比值并归一化。间歇性跛行(IC)患者术后1、2小时比值显著升高(p<0.05);比值 fold change 大于1.25与30天临床结局改善相关。

要点

  • INVOS/SBP比值 fold change 大于1.25与PAD腔内治疗后30天结局改善相关。
  • IC患者术后1、2小时归一化INVOS/SBP比值显著升高(p<0.05)。
  • INVOS或可作为术中预后辅助工具,尤其适用于IC患者,仍需验证。

核心结论

  • INVOS/SBP比值 fold change 大于1.25与PAD腔内治疗术后结局改善相关。
  • INVOS可能作为有价值的术中预后工具,尤其在IC患者中。

研究设计与样本

  • 前瞻性初步研究,纳入30例接受腔内治疗的PAD患者(含IC与CLI)。
  • 术前将INVOS传感器置于治疗侧足部,于术前、术后及术后1、2、3小时记录测量值。
  • 计算原始INVOS值及INVOS/收缩压(SBP)比值,并归一化至基线得到fold change,30天评估临床结局。

主要发现

  • IC与CLI组术前术后原始INVOS值或SBP值均无显著变化。
  • IC患者术后1、2小时归一化INVOS/SBP比值显著更高(p<0.05)。
  • fold change大于1.25与并发症更少及患者和医生报告的改善率更高相关。

关键数值与推荐

  • INVOS/SBP比值 fold change 大于1.25与更好的临床结局相关。
  • IC患者术后1、2小时归一化INVOS/SBP比值显著升高(p<0.05)。

临床怎么用

  • 围术期使用INVOS测量可能辅助确认手术成功并监测PAD腔内治疗结局。
  • 首次血运重建后INVOS比值低于1.25倍应重新评估并改善患肢血流。

局限性

  • 本研究为可行性及假设生成性初步研究,非为得出确定性结论而设计。
  • 样本量有限(30例),结果需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Peripheral arterial disease (PAD), including intermittent claudication (IC) or critical limb ischemia (CLI), can be treated with endovascular revascularization; however, tools for intraoperative prognostication are limited. The In-Vivo Optical Spectroscopy (INVOS) system, a non-invasive near-infrared spectroscopy device, measures tissue oxygenation. This pilot study aims to investigate the use of INVOS during endovascular surgery for PAD as a prognostic tool for endovascular PAD treatment. This study is intended as a feasibility and hypothesis-generating pilot, rather than one designed to draw definitive conclusions. METHODS: Thirty patients with PAD undergoing endovascular treatment were prospectively enrolled. In-Vivo Optical Spectroscopy sensors were applied to the treated foot preoperatively. Measurements were recorded preoperatively, postoperatively, and at 1, 2, and 3 hours post-surgery. Raw INVOS values and INVOS/systolic blood pressure (SBP) ratios were calculated and normalized to baseline values to determine fold changes. Clinical outcomes were assessed at 30 days. RESULTS: No significant changes in raw INVOS or SBP values were observed before or after the procedure in both IC and CLI groups. However, the normalized INVOS/SBP ratio was significantly higher in IC patients at 1 and 2 hours postoperatively (p<0.05). A fold change greater than 1.25 was associated with better clinical outcomes, including fewer complications and higher rates of patient- and physician-reported improvement. CONCLUSION: An INVOS/SBP ratio fold change greater than 1.25-fold is associated with improved outcomes following endovascular intervention for PAD. In-Vivo Optical Spectroscopy may serve as a valuable intraoperative prognostic tool, particularly in IC patients. Further studies are needed to validate these findings.Clinical ImpactThe clinical impact of the current work is to improve the knowledge in the application of INVOS measurements peri operative in clinical practices and improve patients care. Post operative surveillance with INVOS could be used to confirm surgical success. INVOS ratio lower than 1.25-fold after first revascularization should be reassessed and improve blood flow towards the limb. Although limited, this pilot study shows that the use of INVOS can be an adjuvanted tool in monitoring surgical outcomes in patients with PAD.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. McGreevy DT, Hörer TM, Petri MH, et al. In-Vivo Optical Spectroscopy (INVOS) as a Prognostic Tool for Peripheral Artery Disease During Endovascular Intervention: A Pilot Study. J Endovasc Ther. 2025. PMID: 41035344. doi:10.1177/15266028251380182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。